PRESS RELEASE published on 08/23/2024 at 08:01, 1 year 6 months ago Thor Explorations Announces Financial and Operating Results, for the Three and Six Months Ending June 30, 2024 Thor Explorations Ltd. announces financial and operating results for Q2 and H1 2024, including increased revenue, EBITDA, and net profit. Operational highlights for Segilola Gold mine and exploration activities Financial Results Exploration Activities Operating Results Thor Explorations Ltd. Segilola Gold Mine
PRESS RELEASE published on 08/23/2024 at 08:00, 1 year 6 months ago SWEF: July 2024 NAV Starwood European Real Estate Finance Ltd (SWEF) announces unaudited net asset value (NAV) of 104.28p per Ordinary Share as of 31 July 2024 London Stock Exchange Net Asset Value SWEF NAV 31 July 2024
PRESS RELEASE published on 08/23/2024 at 08:00, 1 year 6 months ago Cairn Homes Plc: Transaction in Own Shares Cairn Homes Plc announces the repurchase and cancellation of 100,000 ordinary shares. Details of the transactions and the impact on total shares in issue provided London Stock Exchange Ordinary Shares Share Buyback Cairn Homes Plc Euronext Dublin
PRESS RELEASE published on 08/23/2024 at 08:00, 1 year 6 months ago Petrofac Limited: PETROFAC EXTENDS FORBEARANCE AGREEMENT Petrofac extends forbearance agreement for non-payment of interest coupon on senior secured notes until 20 September 2024, providing time for financial restructuring Senior Secured Notes Financial Restructuring Forbearance Agreement Petrofac Interest Coupon
PRESS RELEASE published on 08/23/2024 at 08:00, 1 year 6 months ago Ondine Biomedical Inc - Steriwave in all British Columbia Health Authorities Ondine Biomedical announces full deployment of Steriwave nasal decolonization in all five of British Columbia's health authorities, enhancing antimicrobial technology to prevent hospital infections British Columbia Nasal Decolonization Steriwave Ondine Biomedical Antimicrobial Technology
PRESS RELEASE published on 08/23/2024 at 07:46, 1 year 6 months ago EQS-Adhoc: infas Holding Aktiengesellschaft: Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014 infas Holding Aktiengesellschaft receives voluntary public takeover offer from Ipsos at EUR 6.80/share. Majority shareholders commit to acceptance Ipsos Infas Holding Voluntary Takeover EUR 6.80 Majority Shareholders
PRESS RELEASE published on 08/23/2024 at 07:30, 1 year 6 months ago The Platform Group AG: First half-year with significant growth and increase in profitability The Platform Group AG reports significant growth and profitability in the first half of 2024 with GMV up 20% to EUR 442.5 million and net sales up 23% to EUR 231.5 million. Forecast for 2024 confirms strong performance Profitability Forecast 2024 Growth Platform Group AG
PRESS RELEASE published on 08/23/2024 at 07:25, 1 year 6 months ago EQS-WpÜG: Takeover Offer / Target company: Infas Holding AG; Bidder: Alsterhöhe 15. V V AG (zukünftig firmierend: Ipsos DACH Holding AG) Alsterhöhe 15. V V AG announces voluntary public takeover offer for infas Holding AG, offering EUR 6.80/share. Bidder enters tender agreements with major shareholders. Details at www.2024-offer.com Offer Document Takeover Offer Ipsos DACH Holding AG Infas Holding AG Tender Agreements
PRESS RELEASE published on 08/23/2024 at 07:25, 1 year 6 months ago Ministry of Health, Labour and Welfare in Japan Approves Partial Change Application for Moderna's COVID-19 mRNA Vaccine Targeting SARS-COV-2 Variant JN.1 Moderna receives approval in Japan for updated Spikevax vaccine targeting SARS-CoV-2 variant JN.1, aligning with WHO recommendations, to be part of Japan's national immunization program COVID-19 Vaccine Japan Moderna SARS-CoV-2 Spikevax
REGULATED PRESS RELEASE published on 08/23/2024 at 06:45, 1 year 6 months ago SHARE CAPITAL AND COMPUTATION OF VOTING RIGHTS AS AT 31.07.24 Declaration of share capital and computation of voting rights for MANITOU BF, in compliance with article 223-16 of AMF regulations. Share value: 1€. Effective voting rights for shareholders' meeting provided Share Capital Voting Rights MANITOU BF Compliance AMF Regulations
Published on 03/12/2026 at 12:30, 13 minutes ago Nextech3D.ai Signs Three-Year Enterprise 3D Modeling and Augmented Reality E-Commerce Contract Valued at Approximately $175,000
Published on 03/12/2026 at 12:30, 13 minutes ago Orogen Royalties Announces Non-Brokered Private Placement of up to $10 Million
Published on 03/12/2026 at 12:30, 13 minutes ago Sparton Provides An Update On VRB Energy Inc. Activities
Published on 03/12/2026 at 12:23, 20 minutes ago SLAM Raises $2,072,750 From Oversubscribed Private Placement
Published on 03/12/2026 at 12:00, 43 minutes ago Significant Gallium and Scandium Confirmed at La Blache as RCL Technology Platform Builds Additional Value
Published on 03/12/2026 at 11:59, 44 minutes ago Aperam added to BEL 20 index by Euronext following 2026 annual review
Published on 03/12/2026 at 11:59, 44 minutes ago Aperam added to BEL 20 index by Euronext following 2026 annual review
Published on 03/12/2026 at 11:30, 1 hour 12 minutes ago Roborock Becomes the World's No. 1 Smart Cleaning Robot Brand, According to IDC
Published on 03/12/2026 at 11:00, 1 hour 43 minutes ago Merger with impact: MG Health and Canify form an international leading medical cannabis provider
Published on 03/12/2026 at 11:00, 1 hour 43 minutes ago ABB Ltd: ABB share buybacks - March 5, 2026 - March 11, 2026
Published on 03/12/2026 at 10:55, 1 hour 47 minutes ago Déclaration des transactions sur actions propres réalisées le 09/03/2026
Published on 03/12/2026 at 10:55, 1 hour 47 minutes ago Statement of transactions in own shares on March 9th, 2026
Published on 03/12/2026 at 08:30, 4 hours 13 minutes ago Claude Bernard lance Claude Bernard Compléments alimentaires en partenariat avec Synadiet
Published on 03/12/2026 at 07:30, 5 hours 13 minutes ago Biophytis-LynxKite Alliance Expands to Turbocharge AI-driven drug discovery for next generation longevity therapeutics
Published on 03/12/2026 at 07:30, 5 hours 13 minutes ago Biophytis et LynxKite renforcent leur alliance pour accélérer la découverte de médicaments dédiés à la longévité grâce à l’IA